Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Xiulian Lu"'
Autor:
Zonglin Han, Xiulian Lu, Yuxiang He, Tangshan Zhang, Zhengtong Zhou, Jingyong Zhang, Hua Zhou
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundAbdominal aortic aneurysm (AAA) is a serious life-threatening vascular disease, and its ferroptosis/cuproptosis markers have not yet been characterized. This study was aiming to identify markers associated with ferroptosis/cuproptosis in AA
Externí odkaz:
https://doaj.org/article/8e12eaa1b5c34b62bbda515e01e0fca8
Autor:
Qingbin Liu, Jingjing Qi, Weiyang Li, Xinchen Tian, Jiaqi Zhang, Fen Liu, Xiulian Lu, Hengchang Zang, Chenqiao Liu, Changlin Ma, Yong Yu, Shulong Jiang
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Methyltransferase-like 3 (METTL3) is the key subunit of methyltransferase complex responsible for catalyzing N6-methyladenosine (m6A) modification on mRNA, which is the most prevalent post-transcriptional modification in eukaryotes. In this
Externí odkaz:
https://doaj.org/article/e596460f11f749ebbc20e9132af02f80
Autor:
Xueying Mao, Yue Chen, Xiulian Lu, Shuiping Jin, Piao Jiang, Zhangfeng Deng, Xiaoyun Zhu, Qichun Cai, Changyou Wu, Shuangpeng Kang
Publikováno v:
Journal of Cancer. 14:1223-1231
Purpose Most malignant effusion are secondary to metastases to the pleura or peritoneum and portend poor oncological outcomes. Malignant effusion have different tumor microenvironment from primary tumor, containing a variety of cytokines and immune c
Autor:
Shulong Shi, Sihao Zhao, Xinchen Tian, Fen Liu, Xiulian Lu, Hengchang Zang, Feng Li, Longquan Xiang, Luning Li, Shulong Jiang
Publikováno v:
Computers in Biology and Medicine. 157:106777
Autor:
Zijie Xiong, Mengjia Jiang, Menghan Zhang, Yilei Qiu, Dashun Zhang, Xicha Lin, Zhuoga Lamu, Gama Zhuoga, Junwei Zhen, Hongliang Li, Xiulian Lu, Zhiping Wu
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 179
Certain ruthenium compounds are found to be potent growth inhibitors for cancer cells. In the current study, a novel ruthenium-triphenylphosphine (PPh
Autor:
Xiulian Lu, Xuewen Wang, Aimin Li, Tong Zhou, Lei Zhang, Jian Qu, Zhijie Mao, Ximiao Gu, Xin Zhang, Su Jing
Publikováno v:
Dyes and Pigments. 205:110586
Publikováno v:
RSC advances. 11(41)
In the current study, six ferrocenylseleno-dopamine derivatives with different structural parameters were designed. Among these derivatives, F4b, containing two ferrocene units and a tertiary amine, showed in vitro anticancer activity with IC50 = 2.4
Autor:
Amy Guan, Bo Gao, Ning Li, Chengde Wu, Jian Li, Yongguo Li, Yan Pan, Liang Shen, Miao He, Lei Huang, Jikui Sun, Yu Tao, Chichung Chan, Gong Zhen, Hongyu Yuan, Li Yi, Zhengang Peng, Li Jie, Xiulian Lu, Chen Shuhui, Dongling Hao
Publikováno v:
ACS Medicinal Chemistry Letters. 9:256-261
[Image: see text] The identification and lead optimization of a series of pyridopyrimidinone derivatives are described as a novel class of efficacious dual PI3K/mTOR inhibitors, resulting in the discovery of 31. Compound 31 exhibited high enzyme acti
Publikováno v:
Micro & Nano Letters. 10:666-669
A series of MnO 2 /carbon nanotubes (CNTs) catalysts were prepared to use for the selective catalytic reduction (SCR) of NO with NH 3 via liquid-phase redox method at ambient temperature. The resulting samples possessed an amorphous MnO 2 and, a high
Publikováno v:
Catalysis Communications. 62:57-61
A novel redox co-precipitation method was firstly adopted to prepare the Mn–FeO x /CNTs catalysts for use in low-temperature NO reduction with NH 3 . The catalysts were possessed of amorphous structure and exhibited 80–100% NO conversion at 140